As heart failure with preserved ejection fraction (HFpEF) rises to epidemic proportions, major steps in patient management and therapeutic development are badly needed. With the current position paper we seek to update our view on HFpEF as a highly complex systemic syndrome, from risk factors and mechanisms to long-term clinical manifestations. We will revise recent advances in animal model development, experimental set-ups and basic and translational science approaches to HFpEF research, highlighting their drawbacks and advantages. Directions are provided for proper model selection as well as for integrative functional evaluation from the in vivo setting to in vitro cell function testing. Additionally, we address new research challenges th...
Background--Among the growing numbers of patients with heart failure, up to one half have heart fail...
At this moment, more than 230,000 people in the Netherlands suffer from heart failure. More than hal...
Background: Information on the pathophysiological differences between heart failure with reduced eje...
As heart failure with preserved ejection fraction (HFpEF) rises to epidemic proportions, major steps...
As heart failure with preserved ejection fraction (HFpEF) rises to epidemic proportions, major steps...
Heart failure with preserved ejection fraction (HFpEF) is increasing in incidence and has a higher p...
Heart failure with preserved ejection fraction (HFpEF) is a complex clinical syndrome responsible fo...
Heart failure (HF) with preserved left ventricular ejection fraction (HFpEF) is becoming the predomi...
Heart failure (HF) with preserved ejection fraction (HFpEF) is a multifactorial disease accounting f...
Background: Information on the pathophysiological differences between heart failure with reduced e...
In contrast to the wealth of proven therapies for heart failure with reduced ejection fraction (HFrE...
There is a lack of consensus on how we define heart failure with preserved ejection fraction (HFpEF)...
Background--Among the growing numbers of patients with heart failure, up to one half have heart fail...
At this moment, more than 230,000 people in the Netherlands suffer from heart failure. More than hal...
Background: Information on the pathophysiological differences between heart failure with reduced eje...
As heart failure with preserved ejection fraction (HFpEF) rises to epidemic proportions, major steps...
As heart failure with preserved ejection fraction (HFpEF) rises to epidemic proportions, major steps...
Heart failure with preserved ejection fraction (HFpEF) is increasing in incidence and has a higher p...
Heart failure with preserved ejection fraction (HFpEF) is a complex clinical syndrome responsible fo...
Heart failure (HF) with preserved left ventricular ejection fraction (HFpEF) is becoming the predomi...
Heart failure (HF) with preserved ejection fraction (HFpEF) is a multifactorial disease accounting f...
Background: Information on the pathophysiological differences between heart failure with reduced e...
In contrast to the wealth of proven therapies for heart failure with reduced ejection fraction (HFrE...
There is a lack of consensus on how we define heart failure with preserved ejection fraction (HFpEF)...
Background--Among the growing numbers of patients with heart failure, up to one half have heart fail...
At this moment, more than 230,000 people in the Netherlands suffer from heart failure. More than hal...
Background: Information on the pathophysiological differences between heart failure with reduced eje...